Hide metadata

dc.contributor.authorSteen, Nils E
dc.contributor.authorAas, Monica
dc.contributor.authorSimonsen, Carmen
dc.contributor.authorDieset, Ingrid
dc.contributor.authorTesli, Martin
dc.contributor.authorNerhus, Mari
dc.contributor.authorGardsjord, Erlend
dc.contributor.authorMørch, Ragni
dc.contributor.authorAgartz, Ingrid
dc.contributor.authorMelle, Ingrid
dc.contributor.authorVaskinn, Anja
dc.contributor.authorSpigset, Olav
dc.contributor.authorAndreassen, Ole A
dc.date.accessioned2016-12-13T05:43:20Z
dc.date.available2016-12-13T05:43:20Z
dc.date.issued2016
dc.identifier.citationInternational Journal of Bipolar Disorders. 2016 Dec 09;4(1):24
dc.identifier.urihttp://hdl.handle.net/10852/53258
dc.description.abstractBackground Mood stabilizers like lithium and anticonvulsants are used in bipolar and related psychotic disorders. There is a lack of knowledge of the relationship of these medications and cognition in the psychosis spectrum. We studied the association between serum concentration of mood stabilizers and cognitive performance in a well-characterized sample of bipolar and schizophrenia spectrum disorders. Methods Serum concentrations of valproate, lamotrigine, and lithium were analyzed for associations to performance on neuropsychological tests in six cognitive domains in individuals with bipolar disorder (n = 167) and in a combined sample of individuals with bipolar or schizophrenia spectrum disorders (n = 217). Linear regression with adjustments for gender, age, and symptom levels of depression, mania, and psychosis were applied for the association analyses. Results There were negative associations between serum levels of valproate and short term delayed recall (bipolar: p = 0.043; combined: p = 0.044) and working memory (bipolar: p = 0.043). A positive association was suggested between serum level of lithium and working memory (bipolar: p = 0.039). There were no other significant relationships between serum levels of valproate, lamotrigine, or lithium and neuropsychological test performance in neither the bipolar disorder nor the combined group. Conclusions Serum levels of mood stabilizers were unrelated to cognitive performance in most domains, indicating that higher dose does not lead to broader cognitive impairments in bipolar and related psychotic disorder patients. However, worsened memory with increasing levels of valproate suggests cautious dosing of anticonvulsants, while increasing lithium level seems to be associated with improved memory. The findings should be interpreted with caution due to the explorative, naturalistic design.
dc.language.isoeng
dc.rightsThe Author(s); licensee Springer International Publishing Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleSerum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting
dc.typeJournal article
dc.date.updated2016-12-13T05:43:21Z
dc.creator.authorSteen, Nils E
dc.creator.authorAas, Monica
dc.creator.authorSimonsen, Carmen
dc.creator.authorDieset, Ingrid
dc.creator.authorTesli, Martin
dc.creator.authorNerhus, Mari
dc.creator.authorGardsjord, Erlend
dc.creator.authorMørch, Ragni
dc.creator.authorAgartz, Ingrid
dc.creator.authorMelle, Ingrid
dc.creator.authorVaskinn, Anja
dc.creator.authorSpigset, Olav
dc.creator.authorAndreassen, Ole A
dc.identifier.doihttp://dx.doi.org/10.1186/s40345-016-0067-z
dc.identifier.urnURN:NBN:no-56524
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/53258/1/40345_2016_Article_67.pdf
dc.type.versionPublishedVersion
cristin.articleid24


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International